Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial

This double-blind placebo-controlled, fixed/flexible-dose phase 2 trial assessed the efficacy, safety, and tolerability of cariprazine vs. placebo for depressive episodes associated with bipolar I or II disorder. Primary endpoint was change in Montgomery–Åsberg Depression Rating Scale (MADRS) total...

Descripción completa

Detalles Bibliográficos
Autores principales: Yatham, Lakshmi N., Vieta, Eduard, Earley, Willie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099842/
https://www.ncbi.nlm.nih.gov/pubmed/32058426
http://dx.doi.org/10.1097/YIC.0000000000000307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099842/
https://www.ncbi.nlm.nih.gov/pubmed/32058426
http://dx.doi.org/10.1097/YIC.0000000000000307

Ejemplares similares